Sovereign Financial Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-5
| Closed | -$3.68K | – | 255 |
|
2023
Q3 | $3.68K | Sell |
5
-11
| -69% | -$8.1K | ﹤0.01% | 226 |
|
2023
Q2 | $72K | Sell |
16
-4
| -20% | -$18K | 0.02% | 228 |
|
2023
Q1 | $51.8K | Hold |
20
| – | – | 0.02% | 213 |
|
2022
Q4 | $50.9K | Hold |
20
| – | – | 0.02% | 217 |
|
2022
Q3 | $77K | Hold |
20
| – | – | 0.03% | 200 |
|
2022
Q2 | $51K | Hold |
20
| – | – | 0.02% | 208 |
|
2022
Q1 | $63K | Buy |
+20
| New | +$63K | 0.02% | 215 |
|
2021
Q4 | – | Sell |
-5
| Closed | -$48K | – | 218 |
|
2021
Q3 | $48K | Buy |
+5
| New | +$48K | 0.03% | 167 |
|